Page 24 - 《中国药房》2022年1期
P. 24
Cell Res,2011,317(10):1437-1453. cals,metals and antioxidants in oxidative stress-induced
[11] ESUMI K,NISHIDA M,SHAW D,et al. NADH measure- cancer[J]. Chem Biol Interact,2006,160(1):1-40.
ments in adult rat myocytes during simulated ischemia[J]. [20] SIES H. Oxidative stress:oxidants and antioxidants[J].
Am J Physiol,1991,260(6 Pt 2):H1743-H1752. Exp Physiol,1997,82(2):291-295.
[12] RESHMA P L,LEKSHMI V S,SANKAR V,et al. Tribu- [21] 阿瓦古丽·达吾提,方莲花,杜冠华.丹酚酸对缺血性心脏
lus terrestris(linn.)attenuates cellular alterations induced 病的作用及作用机制研究进展[J].药学学报,2021,56
by ischemia in H9c2 cells via antioxidant potential[J]. (2):368-373.
Phytother Res,2015,29(6):933-943. [22] JI C C,SONG F,HUANG G Y,et al. The protective
[13] RESHMA P L,BINU P,ANUPAMA N,et al. Pretreat- effects of acupoint gel embedding on rats with myocardial
ment of Tribulus terrestris L. causes anti-ischemic cardio- ischemia-reperfusion injury[J]. Life Sci,2018,211:51-62.
protection through MAPK mediated anti-apoptotic path- [23] MASUDA T,YAMADA K,MAEKAWA T,et al. Antioxi-
way in rat[J]. Biomed Pharmacother,2019,111:1342- dant mechanism studies on ferulic acid:isolation and
1352. structure identification of the main antioxidation product
[14] KIKUZAKI H,HISAMOTO M,HIROSE K,et al. Antioxi- from methyl ferulate[J]. Food Sci Technol Res,2006,12
dant properties of ferulic acid and its related com- (3):173-177.
pounds[J]. J Agric Food Chem,2002,50(7):2161-2168. [24] MCCULLY J D,ROUSOU A J,PARKER R A,et al. Age-
[15] OU S Y,KWOK K C. Ferulic acid:pharmaceutical func- and gender-related differences in mitochondrial oxygen
tions,preparation and applications in foods[J]. J Sci Food consumption and calcium with cardioplegia and diazoxide
Agric,2004,84(11):1261-1269. [J]. Ann Thorac Surg,2007,83(3):1102-1109.
[16] WANG F,PENG Q Q,LIU J F,et al. A novel ferulic acid [25] JIA P Y,LIU C T,WU N,et al. Agomelatine protects
derivative attenuates myocardial cell hypoxia reoxygena- against myocardial ischemia reperfusion injury by inhibi-
tion injury through a succinate dehydrogenase dependent ting mitochondrial permeability transition pore opening[J].
antioxidant mechanism[J]. Eur J Pharmacol,2019,856: Am J Transl Res,2018,10(5):1310-1323.
172417. [26] ZHANG C,YUAN X R,HU Z L,et al. Valproic acid pro-
[17] 王献钊,刘明娣.阿魏酸及阿魏酸乙酯的合成[J].湖南城 tects primary dopamine neurons from MPP -induced neu-
+
市学院学报(自然科学版),2007,16(4):63-65. rotoxicity:involvement of GSK3β phosphorylation by Akt
[18] CHANG S S,LEE V S,TSENG Y L,et al. Gallic acid at- and ERK through the mitochondrial intrinsic apoptotic
tenuates platelet activation and platelet-leukocyte aggrega- pathway[J]. Biomed Res Int,2017,2017:8124501.
tion:involving pathways of Akt and GSK3β[J]. Evid Based (收稿日期:2021-08-17 修回日期:2021-12-02)
Complement Alternat Med,2012,2012:683872. (编辑:舒安琴)
[19] VALKO M,RHODES C J,MONCOL J,et al. Free radi-
(上接第12页) 1978,2(6):429-444.
[12] 王庆金,王强,周雪.区域高技术产业研发活动效率评价 [18] KAO C A,HWANG S N. Efficiency decomposition in
及影响因素研究[J].科技进步与对策,2018,35(23): two-stage data envelopment analysis:an application to
59-65. non-life insurance companies in Taiwan[J]. Eur J Oper
[13] 韩兵,苏屹,李彤,等.基于两阶段 DEA 的高技术企业技 Res,2008,185(1):418-429.
术创新绩效研究[J].科研管理,2018,39(3):11-19. [19] 王辉,陈敏.基于两阶段 DEA 模型的高校科技创新对区
[14] 刘和东,陈文潇.高新技术企业创新系统“黑箱”解构及效 域创新绩效影响[J].经济地理,2020,40(8):27-35,42.
率评价[J].科技进步与对策,2019,36(3):117-122. [20] 王新红,薛泽蓉,张行.基于两阶段DEA模型的混合所有
[15] 郑义,董朝晖,董丽娟,等.我国上市医药企业技术创新效 制企业创新效率测度研究:基于制造业上市企业的经验
率及影响因素研究[J].现代商贸工业,2019,40(18): 数据[J].科技管理研究,2018,38(14):61-67.
12-16. [21] 陈莹文,王美强,陈银银,等.基于改进两阶段 DEA 的中
[16] 杨茜.基于共享投入关联DEA的上市医药制造企业创新 国高技术产业研发创新效率研究[J].软科学,2018,32
效率评价研究[D].绵阳:西南科技大学,2018. (9):14-18.
[17] CHARNES A,COOPER W W,RHODES E. Measuring (收稿日期:2021-06-08 修回日期:2021-11-03)
the efficiency of decision making units[J]. Eur J Oper Res, (编辑:刘明伟)
·18 · China Pharmacy 2022 Vol. 33 No. 1 中国药房 2022年第33卷第1期